Humana Inc. (NYSE:HUM) Shares Purchased by Metis Global Partners LLC

Metis Global Partners LLC boosted its position in Humana Inc. (NYSE:HUM) by 4.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,237 shares of the insurance provider’s stock after purchasing an additional 235 shares during the quarter. Metis Global Partners LLC’s holdings in Humana were worth $1,329,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the company. US Bancorp DE raised its stake in Humana by 0.5% in the 4th quarter. US Bancorp DE now owns 28,459 shares of the insurance provider’s stock valued at $7,220,000 after purchasing an additional 144 shares during the last quarter. Dynasty Wealth Management LLC acquired a new position in Humana in the 4th quarter valued at about $231,000. Versor Investments LP raised its stake in Humana by 120.6% in the 4th quarter. Versor Investments LP now owns 3,397 shares of the insurance provider’s stock valued at $862,000 after purchasing an additional 1,857 shares during the last quarter. Heritage Oak Wealth Advisors LLC acquired a new position in Humana in the 4th quarter valued at about $2,342,000. Finally, Proficio Capital Partners LLC purchased a new stake in Humana in the 4th quarter valued at about $14,097,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

Shares of HUM opened at $261.65 on Tuesday. The business’s 50 day moving average is $271.23 and its two-hundred day moving average is $285.69. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The firm has a market cap of $31.57 billion, a price-to-earnings ratio of 26.30, a PEG ratio of 2.05 and a beta of 0.56. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s payout ratio is 35.58%.

Analyst Ratings Changes

Several analysts have commented on HUM shares. Wells Fargo & Company lowered their price target on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Barclays lifted their price target on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. StockNews.com upgraded Humana from a “hold” rating to a “buy” rating in a report on Tuesday, February 25th. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and lifted their price target for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $285.68.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.32% of the stock is currently owned by corporate insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.